Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aspirin as a Promising Agent to Attenuate Inflammation in the Wall of Human Cerebral Aneurysms

NCT01710072 is registered in ClinicalTrials.gov with University of Iowa as lead sponsor.

NCT NCT01710072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01710072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aspirin as a Promising Agent to Attenuate Inflammation in the Wall of Human Cerebral Aneurysms
Lead sponsor
University of Iowa
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2011
Completion date
August 31, 2014
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

the focus of the study is to monitor mri signal changes and inflammatory biomarkers with use of aspirin in patients with unruptured cerebral aneurysm